Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Share Price
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
25/08/2026
|
5-day change | 1st Jan Change | ||
| 10.31 CNY | +3.10% |
|
-1.43% | -12.55% |
| Market Cap | 13.8B 2.05B 1.76B 1.65B 1.51B 2.85B 196B 2.86B 19.56B 7.58B 98.73B 7.7B 7.54B 327B | P/E 2026 * |
17.9x | P/E 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.37B 1.84B 1.58B 1.48B 1.35B 2.55B 175B 2.57B 17.54B 6.8B 88.52B 6.91B 6.76B 293B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 2.31x |
| Free-Float |
14.33% | Yield 2026 * |
0.67% | Yield 2027 * | 0.77% |
| 1 day | +3.10% | ||
| 1 week | -1.43% | ||
| Current month | +6.40% | ||
| 1 month | +10.39% | ||
| 3 months | +2.28% | ||
| 6 months | -15.70% | ||
| Current year | -12.55% |
| 1 week | 9.91 |  | 11.57 |
| 1 month | 9.32 | | 11.57 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 13.46 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 20/04/1998 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 20/04/1998 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 20/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 20/04/1998 |
Li Li
CHM | Chairman | 62 | 20/04/1998 |
Yu Shan
BRD | Director/Board Member | 65 | 20/04/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/05/23 | Sell | 11,200 | 0.0009% | |||
| 26/05/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.10% | -1.43% | -23.46% | -6.44% | 2.05B | |
| -0.19% | -4.60% | +61.71% | +114.33% | 1,060B | |
| -1.30% | -0.28% | +50.81% | +62.29% | 651B | |
| -1.56% | -0.92% | +24.68% | +75.95% | 465B | |
| -1.41% | -2.29% | +38.35% | +40.19% | 365B | |
| -1.93% | -1.17% | +22.44% | +38.03% | 300B | |
| -0.76% | +0.83% | +2.34% | +12.46% | 258B | |
| +0.02% | +1.46% | +52.82% | +71.53% | 238B | |
| -3.40% | -0.61% | -17.48% | -54.47% | 210B | |
| +0.38% | +3.39% | +30.18% | +92.50% | 184B | |
| Average | -0.69% | -0.54% | +24.24% | +44.64% | 373.25B | |
| Weighted average by Cap. | -0.97% | -2.15% | +39.03% | +66.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.78B 859M 737M 692M 632M 1.19B 81.93B 1.2B 8.19B 3.17B 41.33B 3.23B 3.16B 137B | 6.27B 933M 801M 752M 687M 1.3B 89.01B 1.3B 8.9B 3.45B 44.91B 3.5B 3.43B 149B |
| Net income | 858M 128M 110M 103M 93.88M 177M 12.17B 178M 1.22B 471M 6.14B 479M 469M 20.33B | 999M 149M 127M 120M 109M 206M 14.17B 207M 1.42B 549M 7.15B 558M 546M 23.67B |
| Net Debt | -1.43B -212M -182M -171M -156M -295M -20.24B -296M -2.02B -784M -10.21B -797M -780M -33.82B | 668M 99.31M 85.24M 80.01M 73.07M 138M 9.47B 139M 947M 367M 4.78B 373M 365M 15.83B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/08/26 | CN¥10.60 | +1.92% | 6,685,978 |
| 26/08/26 | CN¥10.40 | +0.87% | 8,545,934 |
| 25/08/26 | CN¥10.31 | +3.10% | 9,611,128 |
| 24/08/26 | CN¥10.00 | -4.49% | 12,512,234 |
| 21/08/26 | CN¥10.47 | -7.18% | 22,933,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
